A positive-control, natural exposure noninferiority field study was conducted to test the efficacy of a novel glycolic acid-based postmilking barrier teat disinfectant compared with a commercial iodine-based postmilking barrier teat disinfectant (positive control). Cows from 2 pens from a California Central Valley dairy farm were dipped after milking either with the positive-control product (PC) or the experimental product (EX) over 12 wk. New intramammary infections (NIMI) were determined by biweekly sampling of all quarters of study cows and classified as a NIMI based on somatic cell count and milk bacteriological culture results. The mean quarter-level incidence risks during a 2 wk study period were 3.50% (EX) and 4.28% (PC). The majority of NIMI were caused by coagulase-negative staphylococci, followed by non-agalactiae streptococci. The study results indicated that EX was noninferior to PC, with a 17% relative efficacy (improvement) in reducing NIMI compared with the PC group. Also, quarter somatic cell count was not affected by the postmilking teat disinfectant used. Finally, the EX product was safe in terms of teat conditioning: teat condition scores were not different between study groups. The study concluded that the glycolic acid-based experimental post-dip barrier was noninferior to the control, and could be considered a safe and effective postmilking teat disinfectant.

The use of beef semen on dairy cows has been increasing steadily since 2017. We aimed to describe dairy management practices toward the use of beef semen by surveying farmers in California, the largest US dairy producer. In January 2020, we mailed a printed version of the beef semen use survey to 1,017 dairy producers in California, who also had the option to answer the survey online. The questionnaire consisted of 33 questions that were categorized into three sections: general herd information (n = 10), beef semen management (n = 17), and sexed dairy semen management (n = 6). The response rate was 13.9% (n = 141). Regression models were used to evaluate the associations between the dairy-beef crossbred sale price, use of beef semen, and use of sexed dairy semen vs. herd characteristics. The mean ± SD herd size was 1,693 ± 1,311 milking cows. Most dairies (81%) reported using beef semen on dairy cows. Among respondents, 78% reported extra profit as the main advantage of using beef semen, followed by control of heifer inventory (69%), genetic improvement (37%), and other factors (8%). Most respondents (58%) started using beef semen in the past 3 years and 34% of the respondents were breeding more than 30% of all the eligible cows with beef semen. Angus semen was the most used (reported by 89% of the respondents), followed by Limousin (12%), Wagyu (10%), Charolais (7%), others (5%, Limflex, Stabilizer, and Hereford), and Simmental (4%). Reproductive performance was an important criterion to select cows to receive beef semen and 45% of the respondents reported starting breeding cows with beef semen from the third breeding, 18% on the fourth breeding, and 21% on the fifth or greater breedings. The region of California (a proxy for type of production system) contracts with a calf ranch and the herd breed explained 76.7% of the observed variation in the day-old dairy beef crossbred calf price. Survey results demonstrated the widespread use of beef semen in dairies and the main breeding strategies adopted by dairy farmers.

No abstract